Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Orion Corp.
Industry Sector: HealthTechnology
CEO: Aino Anna Liisa Hurme, PhD
Number Of Employees: 3,712
Enterprise Value: $6,363,798,108
PE Ratio: 23.33
Exchange/Ticker 1: HSE:ORNAV
Exchange/Ticker 2: HSE:ORNBV
Latest Market Cap: $8,343,859,042
BioCentury | Oct 1, 2024
Deals
Prime narrows gene editing focus with BMS deal
Deals Report: Novartis-Generate use AI to develop protein therapies, and updates from Roche-Regor, CSPC-Alphamab and more
BioCentury | May 7, 2024
Management Tracks
Seaport rounds out C-suite with new hires
Plus: Germany-based Topas taps new CEO, and updates from Quest, Nimbus and more
BioCentury | Jan 25, 2024
Management Tracks
Moeller named CEO of BenevolentAI
Plus: new CFO at Orion and updates from Alkeus and Immorta
BioCentury | Jan 19, 2024
Finance
Public equity roundup: Edgewise shares get lift after $240M offering
Plus offerings by Immatics, Viridion, Alector, LegoChem and more
BioCentury | Mar 23, 2023
Management Tracks
Treco to succeed Bolte as CEO of Inozyme
Plus: Seagen’s Siegall to be CEO at Morphimmune and updates from Jasper, Vividion and more
BioCentury | Nov 29, 2022
Regulation
Nov. 28 Quick Takes: Priority review for Sarepta’s DMD gene therapy
Plus: Science reports second lecanemab death and updates from AZ, C4X, Spectrum, Strand, CinCor and more
BioCentury | Oct 19, 2022
Management Tracks
New chairs at SomaLogic, Anjarium
Plus Dechamps becomes CEO at Bioxodes, and updates from Abalos, M2Gen and Orion
BioCentury | Sep 21, 2022
Management Tracks
New CEOs at Scholar Rock, Neuway, NeuVasQ and ProLynx
Plus Serono’s Maria Rivas joins Pfizer, and updates from
BioCentury | Aug 19, 2022
Deals
Deal for Jemincare PROTAC signals Roche’s aim to expand dealmaking in China
Genentech paying Shanghai biotech $60 million up front for global rights to androgen receptor degrader
BioCentury | Aug 9, 2022
Politics, Policy & Law
Aug. 8 Quick Takes: Insulin cap, carried interest out, drug pricing regulation in
Plus cash crunch for Clovis, tumble for Novavax, clinical updates from CinCor, Reata, Hutchmed, Kodiak and more
Items per page:
1 - 10 of 185